Emerald Health Therapeutics Inc (EMHTF)
0.2006
+0.00 +0.41%
OTC Markets
Jan 15, 12:17
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 9.711M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.594 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -94.06M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -162.7% |
| Profit Margin (Quarterly) | -340.7% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 41.12M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 3.713 |
| PE Ratio | -- |
| Price to Book Value | 0.6768 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.2857 |
| Free Cash Flow (Quarterly) | -0.5731M |
| Return on Equity | Upgrade |
View All EMHTF News
News
-
WireHeadlineTime (ET)
-
MT Newswires12/01 07:03
-
SA Breaking News11/30 18:20
-
SA Breaking News09/01 07:05
-
MT Newswires08/13 07:06
-
SA Breaking News07/24 07:35
-
Globe Newswire07/24 07:00
-
Globe Newswire07/15 21:04
-
Globe Newswire07/01 07:00
-
Globe Newswire06/24 07:00
-
Globe Newswire06/23 06:02
-
Globe Newswire06/23 06:02
-
SA Breaking News06/19 07:03
-
Globe Newswire06/19 07:00
-
Globe Newswire06/11 07:00
-
Globe Newswire06/02 16:05
-
Globe Newswire05/27 19:54
-
Globe Newswire05/25 07:00
-
Globe Newswire05/21 07:00
-
Globe Newswire05/15 07:00
-
Globe Newswire05/14 07:00
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.emeraldhealth.ca
- Investor Relations URL: N/A
- HQ State/Province: British Columbia
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Small Cap/Blend
- Next Earnings Release: N/A
- Last Earnings Release: N/A
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Emerald Health Therapeutics Inc is engaged in the production, distribution, and sale of cannabis products in Canada. Its operating segment includes Cannabis and others. The company generates maximum revenue from the Cannabis segment. Its product includes CBD Oil 25; THC Oil - Indica; THC Oil - Sativa; Island Mist; Big Bud XXL and others.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.2006 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- EMHTF Tweets Stocktwits
Advertisement
